SCHEMBL11167197

SCHEMBL11167197

CCOC(=O)N1CCc2cc(OC)c(OC)c(Sc3ccccc3)c2CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ HPGD P15428 1/20 0.45
▸ MAPT P10636 3/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ TUBB4A P04350 2/20 0.43
▸ TUBB P07437 2/20 0.43
▸ TUBA3C P0DPH7 2/20 0.43
▸ TUBA1B P68363 2/20 0.43
▸ TUBA4A P68366 2/20 0.43
▸ TUBB4B P68371 2/20 0.43
▸ TUBB3 Q13509 2/20 0.43
▸ TUBB2A Q13885 2/20 0.43
▸ TUBB8 Q3ZCM7 2/20 0.43
▸ TUBA3E Q6PEY2 2/20 0.43
▸ TUBA1A Q71U36 2/20 0.43
▸ TUBA1C Q9BQE3 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11160646 0.84 GAA (0.47) ALDH1A1HPGDMAPTKMT2ANPC1
SCHEMBL11160967 0.82 DRD1 (0.47) POLB
Fumaric Acid SCHEMBL11169280 0.81 MEN1 (0.43) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
Fumaric Acid SCHEMBL11169294 0.81 MEN1 (0.43) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL11214362 0.80 LMNA (0.40) ALDH1A1KMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL11169221 0.80 MEN1 (0.39) KMT2AMEN1POLB
SCHEMBL11171000 0.78 DRD1 (0.38) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL11215748 0.77 CYP2D6 (0.41) KMT2AMEN1POLB
SCHEMBL11214359 0.77 KCNH2 (0.46) —
SCHEMBL11197473 0.74 ALDH1A1 (0.59) ALDH1A1MAPTKMT2ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback